Cwa Asset Management Group, LLC Harmony Biosciences Holdings, Inc. Transaction History
Cwa Asset Management Group, LLC
- $1.95 Billion
- Q4 2024
A detailed history of Cwa Asset Management Group, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 18,279 shares of HRMY stock, worth $645,614. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,279
Previous 14,396
26.97%
Holding current value
$645,614
Previous $575,000
9.22%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$234 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$206 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$167 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$80.5 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.09B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...